Acute Migraine Drugs Market Global Acute Migraine Drugs Market Forecasted to Reach $18.6 Billion by 2030   The global acute migraine drugs market is poised for substantial growth, with projections indicating a surge from US$ 10.1 billion in 2022 to an estimated US$ 18.6 billion by 2030, reflecting a robust Compound Annual Growth Rate (CAGR) of 8.1% during the forecast period of 2024-2031....